Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Here are six articles published by Becker's Hospital Review in the last week, highlighting Walmart's patent for a floating warehouse, one drugmaker's 430 percent price hike and more.
The Food and Drug Administration on Monday approved Solco Healthcare's duloxetine delayed-release capsules.
Centurion Labs recalled its Ninjacof and Ninjacof A cold medicine over potential bacterial contamination.
At the amyotrophic lateral sclerosis clinic at Richmond, Va.-based VCU Medical Center, patient access to the first FDA-approved ALS treatment in 20 years remains limited by restricted insurance coverage and the sheer cost of the drug, according to the Richmond…
Aeroflow Healthcare was named to the Inc. 5000's list of fastest growing companies in 2017.
US Bioservices Corp., a specialty pharmacy unit of AmerisourceBergen, agreed to pay $13.4 million to settle allegations that it pushed patients to refill prescriptions for Novartis AG's iron overload drug, Exjade, in exchange for kickbacks, according to Reuters.
The Food and Drug Administration on Aug. 18 released draft guidance outlining ways to help organizations comply with drug distribution security provisions, according to Regulatory Focus.
Two-thirds of Californians do not support a drug price transparency bill before the California State Assembly, according to a recent survey commissioned by the Association for Accessible Medicines.
Tech-giant Samsung will widen its stake in the prescription drug market by producing novel drugs in partnership with Japan's Takeda Pharmaceutical Co., according to Reuters.
Patients across the globe are bracing themselves for the price of CTL019, a new leukemia drug deemed a "breakthrough" by physicians, according to Kaiser Health News.